10-Q: DLH Holdings Corp. Reports Strong Revenue Growth in Q1 2024, Driven by Recent Acquisition
Quarterly Report
DLH Holdings Corp. saw a significant increase in revenue for the quarter ended December 31, 2023, primarily due to a recent acquisition, while also managing debt and maintaining compliance with financial covenants.
Summary
- DLH Holdings Corp. reported a revenue of $97.85 million for the three months ended December 31, 2023, compared to $72.74 million for the same period in 2022.
- The increase in revenue is primarily attributed to the acquisition made in December 2022.
- Net income for the quarter was $2.15 million, or $0.15 per share, compared to $1.55 million, or $0.12 per share, in the prior year.
- The company's backlog was approximately $653.5 million at December 31, 2023, with $132.3 million funded.
- Operating costs increased to $91.03 million from $68.82 million year-over-year, mainly due to higher contract costs.
- Interest expense rose to $4.66 million from $1.83 million due to increased borrowing for the acquisition.
- The company made voluntary prepayments of $10.8 million on its secured term loan during the quarter.
- DLH is in compliance with all loan covenants and restrictions as of December 31, 2023.
Sentiment
Score: 7
Explanation: The document shows strong revenue growth and improved profitability, but also highlights increased debt and operating costs. The overall sentiment is positive, but with some caution due to the financial risks.
Positives
- The company experienced significant revenue growth, primarily driven by the recent acquisition.
- Net income and earnings per share both increased compared to the same period last year.
- The company's backlog remains strong, indicating future revenue potential.
- EBITDA showed a substantial increase, reflecting improved operational performance.
- Voluntary debt prepayments demonstrate a commitment to financial health.
- The company is in compliance with all loan covenants, indicating sound financial management.
Negatives
- Operating costs increased significantly, primarily due to higher contract costs.
- Interest expense rose substantially due to increased borrowing for the acquisition.
- Cash flow from operations decreased compared to the same period last year.
- The company's cash balance decreased to $0.1 million from $0.2 million at the start of the period.
Risks
- The company is dependent on relationships with the VA and HHS, and a loss of these contracts could materially affect results.
- The company faces risks related to government contract procurement, including bid protests and termination risks.
- The company is exposed to the impact of inflation and higher interest rates.
- The company's debt obligations could pose a risk if not managed effectively.
- The company's goodwill could be impaired if business conditions change adversely.
- The company is subject to the risk of government shutdowns and continuing resolutions which may impact business.
Future Outlook
The company aims to expand its position as a trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services. They believe their business development priorities will position the company to expand within top national priority programs and funded areas. The company is monitoring the federal budget outlook for fiscal year 2024 and the potential impact of federal contractual set-aside laws and regulations.
Management Comments
- Management believes that its key programs benefit from bipartisan support and does not expect a material impact on its current business base from budget negotiations.
- Management believes that its past performance in the market and track record of success provide a competitive advantage.
- Management believes that current investment and financing obligations are adequately covered by cash generated from profitable operations.
Industry Context
The company operates in the government contracting sector, providing services to federal agencies such as HHS, VA, and DoD. The company's focus on digital transformation, cybersecurity, and healthcare aligns with current government priorities. The company is also impacted by federal budget cycles and set-aside regulations.
Comparison to Industry Standards
- DLH's revenue growth of approximately 34.5% year-over-year is strong compared to the average growth rate in the government contracting sector, which is typically in the single to low double-digit range.
- The company's EBITDA margin of approximately 11.3% is within the typical range for government contractors, but there is room for improvement.
- DLH's reliance on a few major customers, particularly the VA and HHS, is a common risk in the industry, and the company is actively managing this risk.
- The company's debt levels are higher than some of its peers due to the recent acquisition, but the company is actively managing this debt through prepayments.
- Compared to companies like Leidos and Booz Allen Hamilton, DLH is smaller but is showing strong growth potential.
Stakeholder Impact
- Shareholders will benefit from the increased revenue and profitability.
- Employees may benefit from the company's growth and expansion.
- Customers will continue to receive services from the company.
- Creditors will be impacted by the company's debt management and compliance with loan covenants.
Next Steps
- The company will continue to engage with the VA for further extensions of the bridge contracts for pharmacy and logistics services.
- The company will monitor the federal budget outlook for fiscal year 2024 and the potential impact of federal contractual set-aside laws and regulations.
- The company will continue to review its operations in an attempt to identify programs potentially at risk from continuing resolutions.
Key Dates
| Date | Description |
|---|---|
| 2019-09-19 | DLH executed a floating-to-fixed interest rate swap with First National Bank. |
| 2022-12-08 | The secured term loan and secured revolving line of credit mature on this date. |
| 2022-12-31 | Date of the acquisition that significantly impacted the current quarter's results. |
| 2023-01-31 | DLH executed an additional floating-to-fixed interest rate swap with First National Bank. |
| 2023-09-30 | Prior quarter end for comparison in the balance sheet. |
| 2023-12-31 | End of the reporting period for this quarterly report. |
| 2024-01-19 | The President signed a continuing resolution providing funds to the federal government. |
| 2024-01-30 | Date of the latest practicable date for share information. |
| 2024-01-31 | Date of the filing of this quarterly report. |
| 2024-02-29 | Bridge contracts for VA pharmacy and logistics services expire. |
| 2024-03-01 | Continuing resolution funding expires for several government agencies. |
| 2024-03-08 | Continuing resolution funding expires for the remaining government agencies. |
| 2024-06-07 | Maturity date of the first interest rate swap. |
| 2026-01-31 | Maturity date of the second interest rate swap. |
| 2027-12-08 | Maturity date of the secured term loan and secured revolving line of credit. |
Keywords
government contracts, healthcare, cybersecurity, digital transformation, revenue, EBITDA, backlog, acquisition, debt, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.